Vir Biotechnology
Total 1 Post
Vir Biotechnology is a clinical-stage immunology company, which is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
Samsung Biologics Won a $360 Million Contract for the Production of COVID-19 Vaccine
The total amount of the contract is $360 million. Samsung Biologics will start producing drugs for treating coronavirus infection COVID-19 once Vir Biotechnology completes its development.
